Interventional Recruiting Phase 4
NCT07166939 on ClinicalTrials.gov
45th Multicenter Airway Research Collaboration
Official title: A Phase 4, Multicenter, Cluster Randomized, Open-label, Intervention Versus Usual Care, Controlled Study on the Effect of Emergency Department Initiation of Airsupra on Asthma Outcomes
- Sponsor: Massachusetts General Hospital
- Enrollment: 1860 (Estimated)
- Study start: 2025-11-07 (Actual)
- Primary completion: 2027-06-01 (Estimated)
- Study completion: 2027-06-01 (Estimated)
- Allocation: Randomized
- InterventionModel: Parallel
- InterventionModelDescription: cluster randomized trial
- Masking: None
- PrimaryPurpose: Treatment
Brief Summary
The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Conditions
- Asthma Acute
- Asthma Exacerbation
- Asthma
- Asthma Control Level
Intervention / Treatment
- Drug: Airsupra
Primary Outcome Measures
-
acute asthma recurrence
(3 months)
any urgent or unscheduled visit to a clinician for worsening asthma symptoms during the 3 months after the index ED visit
Countries
United States
Locations and Investigators
-
MetroHealth, Cleveland, United States (Recruiting)
- Charles L Emerman, MD